Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
. Haemophilia. 2001 Jan;7(1):99-102. doi: 10.1046/j.1365-2516.2001.00471.x. Haemophilia. 2001. PMID: 11136389